TAMER, F. Et Al. 2023. Monocyte to high-density lipoprotein cholesterol ratio decreased in patients with psoriasis treated with ixekizumab. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion , vol.75, no.4 , 187-192.

TAMER, F., Kucukhemek, F., & Gulekon, A., (2023). Monocyte to high-density lipoprotein cholesterol ratio decreased in patients with psoriasis treated with ixekizumab. Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion , vol.75, no.4, 187-192.

TAMER, FUNDA, FAHRETTİN KÜÇÜKHEMEK, And Ayla Gulekon. "Monocyte to high-density lipoprotein cholesterol ratio decreased in patients with psoriasis treated with ixekizumab," Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion , vol.75, no.4, 187-192, 2023

TAMER, FUNDA Et Al. "Monocyte to high-density lipoprotein cholesterol ratio decreased in patients with psoriasis treated with ixekizumab." Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion , vol.75, no.4, pp.187-192, 2023

TAMER, F. Kucukhemek, F. And Gulekon, A. (2023) . "Monocyte to high-density lipoprotein cholesterol ratio decreased in patients with psoriasis treated with ixekizumab." Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion , vol.75, no.4, pp.187-192.

@article{article, author={FUNDA TAMER Et Al. }, title={Monocyte to high-density lipoprotein cholesterol ratio decreased in patients with psoriasis treated with ixekizumab}, journal={Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion}, year=2023, pages={187-192} }